skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

30 Total results for product and free and sample content found

Datamonitor Healthcare

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 1

By Jack Allen 08 Jun 2018

Zach McLellan and Jack Allen are joined by guest analysts Dominique Fontanilla and Hardik Patel. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

Topic Cancer

Datamonitor Healthcare

Datamonitor Healthcare Analyst Podcast: Post-ASCO Podcast 2

By Jack Allen 08 Jun 2018

Zach McLellan and Jack Allen are joined by guest analyst Maria Berezina. The group discusses key recent events that occurred at the American Society of Clinical Oncology 2018 Annual Meeting.

Topic Cancer

Datamonitor Healthcare

Approval of Sun Pharmas Yonsa in Prostate Cancer Podcast

By Zachary McLellan 29 May 2018

Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the approval of Sun Pharma's Yonsa in prostate cancer, and broad market commentary on Tesaro, Gilead, Clovis, Portola, BMS and Celgene

Topic Company analysis

Datamonitor Healthcare

Datamonitor Healthcare Podcast 16 February 2018

By Zachary McLellan 15 May 2018

Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including a recap of the 2018 BIO CEO conference, Phase IIb results of aramchol in HIV-lipodystrophy NAFLD or NASH patients, and the approval of Ereleada (apalutamide) in non-metastatic castration-resistant prostate cancer.

Topic Business strategies BioPharmaceutical

Datamonitor Healthcare

Datamonitor Healthcare Podcast 04 April 2018

By Jack Allen 15 May 2018

Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.

Topic Drug development landscape

Datamonitor Healthcare

Podcast - Analyst Opinion on Approval of AndexXa for reversal of Eliquis and Xarelto

By Zachary McLellan 11 May 2018

Zach McLellan, Jack Allen, and guest analyst Cameron Findlater discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the approval of AndexXa for reversal of Eliquis and Xarelto & Eli Lilly's acquisition of ARMO Biosciences.

Datamonitor Healthcare

Datamonitor Healthcare Podcast 16 March 2018

By Jack Allen 11 May 2018

Zach McLellan, Jack Allen, and guest analysts Louisa Joseph and Michael Haydock discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including results for Gilead's new HIV flagship product; Biktarvy, and the US approval of the HIV drug Trogarzo, the first for salvage patients.

Topic Clinical trials Infectious diseases

Datamonitor Healthcare

Datamonitor Healthcare Podcast 13 April 2018

15 Apr 2018

Zach McLellan, Jack Allen, and guest analyst Michael Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the Novartis purchase of AveXis for $8.7 billion as they target gene therapy in SMA.

Topic Company analysis

Medtech Insight

Medtech Insights Device Week Podcast - Approvals And M&A

By David Filmore 12 Mar 2018

In this edition of Device Week, Medtech Insight’s Reed Miller, David Filmore and Catherine Longworth look back at the past year and the key trends in US and international product approvals, as well as in M&A activity. They also give their perspectives on what to look forward to in 2018.

Topic Medtech

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: